These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33510809)

  • 41. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
    Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
    Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
    Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.
    Yang Y; Zhou Y; Cao Z; Tong XZ; Xie HQ; Luo T; Hua XP; Wang HQ
    Exp Ther Med; 2016 Sep; 12(3):1556-1562. PubMed ID: 27588076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.
    Chen A; Li W; Chen X; Shen Y; Dai W; Dong Q; Li X; Ou C; Chen M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):225. PubMed ID: 27855650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
    Makino N; Sugano M; Hata T; Taguchi S; Yanaga T
    Mol Cell Biochem; 1996; 163-164():239-45. PubMed ID: 8974063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of rutaecarpine against t-BHP-induced hepatotoxicity by upregulating antioxidant enzymes via the CaMKII-Akt and Nrf2/ARE pathways.
    Jin SW; Hwang YP; Choi CY; Kim HG; Kim SJ; Kim Y; Chung YC; Lee KJ; Jeong TC; Jeong HG
    Food Chem Toxicol; 2017 Feb; 100():138-148. PubMed ID: 28025122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oleanonic acid ameliorates pressure overload-induced cardiac hypertrophy in rats: The role of PKCζ-NF-κB pathway.
    Gao H; Liu H; Tang T; Huang X; Wang D; Li Y; Huang P; Peng Y
    Mol Cell Endocrinol; 2018 Jul; 470():259-268. PubMed ID: 29138023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
    Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J
    J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testin protects against cardiac hypertrophy by targeting a calcineurin-dependent signalling pathway.
    Gao L; Liu Y; Guo S; Xiao L; Liang C; Wang X
    J Cell Mol Med; 2019 Jan; 23(1):328-339. PubMed ID: 30467953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preliminary Study of Necroptosis in Cardiac Hypertrophy Induced by Pressure Overload].
    Zhao M; Qin Y; Lu L; Tang X; Wu W; Fu H; Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Jun; 32(3):618-23. PubMed ID: 26485988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic heme oxygenase-1 transgenic overexpression aggravates pressure overload-induced cardiac hypertrophy in mice.
    Chen C; Huo R; Tong Y; Sheng Y; Liu HB; Gao X; Nakajima O; Yang BF; Dong DL
    Cell Physiol Biochem; 2011; 28(1):25-32. PubMed ID: 21865845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.
    Wettschureck N; Rütten H; Zywietz A; Gehring D; Wilkie TM; Chen J; Chien KR; Offermanns S
    Nat Med; 2001 Nov; 7(11):1236-40. PubMed ID: 11689889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of endothelial nitric oxide synthase by a vanadium compound ameliorates pressure overload-induced cardiac injury in ovariectomized rats.
    Bhuiyan MS; Shioda N; Shibuya M; Iwabuchi Y; Fukunaga K
    Hypertension; 2009 Jan; 53(1):57-63. PubMed ID: 19029487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy.
    Akers WS; Cross A; Speth R; Dwoskin LP; Cassis LA
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2797-806. PubMed ID: 11087234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy.
    Li R; Wang X; Wu S; Wu Y; Chen H; Xin J; Li H; Lan J; Xue K; Li X; Zhuo C; He J; Tang CS; Jiang W
    J Cell Physiol; 2019 Aug; 234(10):17578-17588. PubMed ID: 30793300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa.
    Moon TC; Murakami M; Kudo I; Son KH; Kim HP; Kang SS; Chang HW
    Inflamm Res; 1999 Dec; 48(12):621-5. PubMed ID: 10669112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
    Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.